4.6 Article

Recruitment times, proliferation, and apoptosis rates during the CD8+ T-Cell response to lymphocytic choriomeningitis virus

Journal

JOURNAL OF VIROLOGY
Volume 75, Issue 22, Pages 10663-10669

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.75.22.10663-10669.2001

Keywords

-

Categories

Funding

  1. NIAID NIH HHS [R01 AI028433, AI28433, R37 AI028433] Funding Source: Medline

Ask authors/readers for more resources

The specific CD8(+) T-cell response during acute lymphocytic choriomeningitis virus (LCMV) infection of mice is characterized by a rapid proliferation phase, followed by a rapid death phase and long-term memory. In BALB/c mice the immunodominant and subdominant CDS' responses are directed against the NP118 and GP283 epitopes. These responses differ mainly in the magnitude of the epitope-specific CDS' T-cell expansion. Using mathematical models together with a nonlinear parameter estimation procedure, we estimate the parameters describing the rates of change during the three phases and thereby establish the differences between the responses to the two epitopes. We find that CDS' cell proliferation begins 1 to 2 days after infection and occurs at an average rate of 3 day(-1), reaching the maximum population size between days 5 and 6 after immunization. The 10-fold difference in expansion to the NP118 and GP283 epitopes can be accounted for in our model by a 3.5-fold difference in the antigen concentration of these epitopes at which T-cell stimulation is half-maximal. As a consequence of this 3.5-fold difference in the epitope concentration needed for T-cell stimulation, the rates of activation and proliferation of T cells specific for the two epitopes differ during the response and in combination can account for the large difference in the magnitude of the response. After the peak, during the death phase, the population declines at a rate of 0.5 day(-1), i.e., cells have an average life time of 2 days. The model accounts for a memory cell population of 5% of the peak population size by a reversal to memory of 1 to 2% of the activated cells per day during the death phase.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available